UA90286U - process for the preparation of substance with potential physiological properties 1,1'-(2"-bromo-2"-chloroethenyl)-bis-(5-mEthyluracil) - Google Patents

process for the preparation of substance with potential physiological properties 1,1'-(2"-bromo-2"-chloroethenyl)-bis-(5-mEthyluracil)

Info

Publication number
UA90286U
UA90286U UAU201311170U UAU201311170U UA90286U UA 90286 U UA90286 U UA 90286U UA U201311170 U UAU201311170 U UA U201311170U UA U201311170 U UAU201311170 U UA U201311170U UA 90286 U UA90286 U UA 90286U
Authority
UA
Ukraine
Prior art keywords
methyluracil
chloroethenyl
bromo
bis
substance
Prior art date
Application number
UAU201311170U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Олена Василівна Вельчинська
Original Assignee
Національний Медичний Університет Імені О.О. Богомольця
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Національний Медичний Університет Імені О.О. Богомольця filed Critical Національний Медичний Університет Імені О.О. Богомольця
Priority to UAU201311170U priority Critical patent/UA90286U/en
Publication of UA90286U publication Critical patent/UA90286U/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A process for the preparation of substance with potential physiological properties 1,1'-(2"-bromo-2"-chloroethenyl)-bis-(5-methyluracil) by interaction of known reactants and components of medicinal agents of 5-methyluracil and halothane in molar ratio of 2:1 in the solvent system (benzene-dimethylformamide-diethyl ether) under conditions of phase-transfer catalysis with dibenzo-18-crown-6-ether.
UAU201311170U 2013-09-20 2013-09-20 process for the preparation of substance with potential physiological properties 1,1'-(2"-bromo-2"-chloroethenyl)-bis-(5-mEthyluracil) UA90286U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201311170U UA90286U (en) 2013-09-20 2013-09-20 process for the preparation of substance with potential physiological properties 1,1'-(2"-bromo-2"-chloroethenyl)-bis-(5-mEthyluracil)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201311170U UA90286U (en) 2013-09-20 2013-09-20 process for the preparation of substance with potential physiological properties 1,1'-(2"-bromo-2"-chloroethenyl)-bis-(5-mEthyluracil)

Publications (1)

Publication Number Publication Date
UA90286U true UA90286U (en) 2014-05-26

Family

ID=56268045

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201311170U UA90286U (en) 2013-09-20 2013-09-20 process for the preparation of substance with potential physiological properties 1,1'-(2"-bromo-2"-chloroethenyl)-bis-(5-mEthyluracil)

Country Status (1)

Country Link
UA (1) UA90286U (en)

Similar Documents

Publication Publication Date Title
MX361218B (en) Spliceostatin analogs.
MX2021008976A (en) Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer.
PH12015501595A1 (en) Spiro-lactam nmda receptor modulators and uses thereof
PH12015501598A1 (en) Spiro-lactam nmda receptor modulators and uses thereof
PH12015501600A1 (en) Spiro-lactam nmda receptor modulators and uses thereof
MY188450A (en) Spiro-lactam nmda receptor modulators and uses thereof
MX2016008448A (en) Var2csa-drug conjugates.
MY181928A (en) Sodium channel modulators for the treatment of pain and diabetes
TN2014000322A1 (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
BR112012032008A2 (en) s100a4 antibodies and therapeutic uses thereof
MX367210B (en) Stable oral solutions for combined api.
EP4360621A3 (en) Formulations of bendamustine
CO7160080A2 (en) Lipid compositions of racecadot
BR112014021497A2 (en) jcv-vlp based drug delivery system
UA119441C2 (en) Glycogen-based water solubility enhancers
UA90286U (en) process for the preparation of substance with potential physiological properties 1,1'-(2"-bromo-2"-chloroethenyl)-bis-(5-mEthyluracil)
UA86146U (en) Process for the preparation of substances with potential physiological properties 1,1'-(2"-bromo-2"-chloroethenyl)-bis-(5-bromouracil)
UA86448U (en) Process for the preparation of substance with potential physiological properties 1,1'-(2"-bromo-2"-chloroethenyl)-bis-(5-nitrouracil)
UA87163U (en) Process for the preparation of substance 1,1'-(2"-bromo-2"-chloroethenyl)-bis-(uracil) with potential physiological properties
UA90820U (en) Process for the preparation of compound with potential physiological properties1,1'-(2"-bromo-2"-chloroethenyl)-bis-(6-methyluracil)
UA87255U (en) Process for the preparation of substance 1-(1',1'-difluoro-2'-bromo-2'-chloroethyl)- 5-methyluracil with potential physiological properties
UA79654U (en) Process for the preparation of a compound 1,1'-(2''-bromo-2''-chloroethenyl)-bis-(imidazole) with potential physiological properties
UA87697U (en) Process for the preparation of substance with potential physiological properties 1-(1',1'-difluoro-2'-bromo-2'-choloroethyl)-6-methyluracil
UA87256U (en) Process for the preparation of substance 1-(1',1'-difluoro-2'-bromo-2'-chloroethyl)-uracil with potential physiological properties
UA82244U (en) Process for the preparation of compound with potential physiological properties 1-(1',1'-difluoro-2'-bromo-2'-chloroethyl)-benzimidazole